Biosimilars Can Help Lower Patient Drug Costs When the Right Teams Come Together: Prime Therapeutics Executive

May 29, 2022

Managed Healthcare Executive

Related news

In the news

April 16, 2024

Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024

Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024

In the news

April 3, 2024

A conversation with Marci J. Chodroff, M.D.

Managed Healthcare Executive (page 9)